323 related articles for article (PubMed ID: 16263422)
1. Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study.
Berger M; Frairia R; Piacibello W; Sanavio F; Palmero A; Venturi C; Pignochino Y; Berta L; Madon E; Aglietta M; Fagioli F
Exp Hematol; 2005 Nov; 33(11):1371-87. PubMed ID: 16263422
[TBL] [Abstract][Full Text] [Related]
2. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
[TBL] [Abstract][Full Text] [Related]
3. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
[TBL] [Abstract][Full Text] [Related]
4. Cobblestone area-forming cells, long-term culture-initiating cells and NOD/SCID repopulating cells in human neonatal blood: a comparison with umbilical cord blood.
Zhang XB; Li K; Fok TF; Li CK; James AE; Lam AC; Lee SM; Yuen PM
Bone Marrow Transplant; 2002 Nov; 30(9):557-64. PubMed ID: 12407429
[TBL] [Abstract][Full Text] [Related]
5. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
Zheng Y; Sun A; Han ZC
Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
[TBL] [Abstract][Full Text] [Related]
6. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
7. Role of different medium and growth factors on placental blood stem cell expansion: an in vitro and in vivo study.
Berger M; Fagioli F; Piacibello W; Sanavio F; Mareschi K; Biasin E; Bruno S; Gammaitoni L; Gunetti M; Nesi F; Madon E; Aglietta M
Bone Marrow Transplant; 2002 Mar; 29(5):443-8. PubMed ID: 11919735
[TBL] [Abstract][Full Text] [Related]
8. [Mesenchymal stem cells from human cord blood promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice].
Zhou DH; Huang SL; Huang K; Wu YF; Bao R; Wei J; Zhang XC; Li Y
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):732-5. PubMed ID: 16620577
[TBL] [Abstract][Full Text] [Related]
9. The plant mannose-binding lectin NTL preserves cord blood haematopoietic stem/progenitor cells in long-term culture and enhances their ex vivo expansion.
Li K; Ooi VE; Chuen CK; Lam AC; Ooi LS; Zhang XB; Tsang KS; Chiu LC; Chan KY; Li CK; Fok TF; Yuen PM; Ng PC
Br J Haematol; 2008 Jan; 140(1):90-8. PubMed ID: 17908183
[TBL] [Abstract][Full Text] [Related]
10. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of ex vivo expansion and engraftment in NOD-SCID mice of umbilical cord blood CD34+ cells using the DIDECO "Pluricell System".
Astori G; Adami V; Mambrini G; Bigi L; Cilli M; Facchini A; Falasca E; Malangone W; Panzani I; Degrassi A
Bone Marrow Transplant; 2005 Jun; 35(11):1101-6. PubMed ID: 15821764
[TBL] [Abstract][Full Text] [Related]
12. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-pretreatment of CD34(+) cord blood stem cells in vitro reduces long-term cell engraftment in NOD/SCID mice.
Wulf-Goldenberg A; Eckert K; Fichtner I
Eur J Cell Biol; 2008 Feb; 87(2):69-80. PubMed ID: 17931741
[TBL] [Abstract][Full Text] [Related]
14. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
[TBL] [Abstract][Full Text] [Related]
15. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.
Madlambayan GJ; Rogers I; Purpura KA; Ito C; Yu M; Kirouac D; Casper RF; Zandstra PW
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1020-30. PubMed ID: 17084368
[TBL] [Abstract][Full Text] [Related]
16. Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions.
Gunetti M; Ferrero I; Rustichelli D; Berger M; Gammaitoni L; Timeus F; Piacibello W; Aglietta M; Fagioli F
Exp Hematol; 2008 Feb; 36(2):235-43. PubMed ID: 18206730
[TBL] [Abstract][Full Text] [Related]
17. Effects of CD34+ selection and T cell immunodepletion on cord blood hematopoietic progenitors: relevance to stem cell transplantation.
Laver J; Traycoff CM; Abdel-Mageed A; Gee A; Lee C; Turner C; Srour EF; Abboud M
Exp Hematol; 1995 Dec; 23(14):1492-6. PubMed ID: 8542936
[TBL] [Abstract][Full Text] [Related]
18. Expansion of HPCs from cord blood in a novel 3D matrix.
Ehring B; Biber K; Upton TM; Plosky D; Pykett M; Rosenzweig M
Cytotherapy; 2003; 5(6):490-9. PubMed ID: 14660045
[TBL] [Abstract][Full Text] [Related]
19. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
[TBL] [Abstract][Full Text] [Related]
20. Efficiency of transgenic T cell generation from gene-marked cultured human CD34+ cord blood cells is determined by their maturity and the cytokines present in the culture medium.
Verhasselt B; Naessens E; De Smedt M; Plum J
Gene Ther; 2000 May; 7(10):830-6. PubMed ID: 10845720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
